Shields, Beverley M.
Dennis, John M. http://orcid.org/0000-0002-7171-732X
Angwin, Catherine D.
Warren, Fiona
Henley, William E.
Farmer, Andrew J. http://orcid.org/0000-0002-6170-4402
Sattar, Naveed http://orcid.org/0000-0002-1604-2593
Holman, Rury R. http://orcid.org/0000-0002-1256-874X
Jones, Angus G. http://orcid.org/0000-0002-0883-7599
Pearson, Ewan R. http://orcid.org/0000-0001-9237-8585
Hattersley, Andrew T. http://orcid.org/0000-0001-5620-473X
,
Funding for this research was provided by:
RCUK | Medical Research Council (MR/N00633X/1, MR/N00633X/1, MR/N00633X/1, MR/N00633X/1, MR/N00633X/1, MR/N00633X/1, MR/N00633X/1, MR/N00633X/1)
RCUK | MRC | Medical Research Foundation (MR/N00633X/1, MR/N00633X/1)
Article History
Received: 4 October 2022
Accepted: 7 November 2022
First Online: 7 December 2022
Competing interests
: N.S. is supported by a BHF Centre of Excellence Award (RE/18/6/34217). R.H. is an Emeritus National Institute for Health Research Senior Investigator. A.H. is a Wellcome Senior Investigator (098395/Z/12/Z) and a Senior Investigator at the NIHR. A.H., B.S., A.J. and C.A. are supported by the NIHR Exeter Clinical Research Facility. A.H., B.S., J.D., A.G. and C.A. are supported by the National Institute for Health and Care Research Exeter Biomedical Research Centre. A.F. receives support from the NIHR Oxford Biomedical Research Centre. E.P. has received honoraria from Eli Lilly, Sanofi and Illumina. N.S. has consulted for and/or received speaker honoraria from Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Merck Sharp & Dohme, Novo Nordisk, Novartis, Sanofi and Pfizer and received grant funding paid to his university from AstraZeneca, Boehringer Ingelheim, Novartis and Roche Diagnostics. R.R.H. reports research support from AstraZeneca, Bayer and Merck Sharp & Dohme and personal fees from Anji Pharmaceuticals, AstraZeneca, Novartis and Novo Nordisk. W.H. has received grant funding from IQVIA and travel funds from Eisai. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.